PRELIMINARY EVALUATION OF GYMNEMA SYLVESTRE EXTRACT-BASED NANONEUTRACEUTICALS

Abstract

Promising phytochemical and physicochemical characteristics were found in early assessment of Gymnema Sylvestre extract-based nanoneutraceuticals. By means of evaluations of foreign organic matter, ash values, and extractive values, all within reasonable limits, standardizing investigations verified the authenticity and purity of the plant material Thin Layer Chromatography (TLC) study further corroborated phytochemical screening results confirming the presence of flavonoids, alkaloids, triterpenoids, and steroids. While spectroscopic methods gave structural understanding of the bioactive chemicals, column chromatography made active fractions possible to separate. These results imply that Gymnema Sylvestre extract has bioactive components with pharmacological significance, hence having great potential for nanoneutraceutical formulations. Investigating its medicinal uses and safety profile will need further research